411 related articles for article (PubMed ID: 34681737)
1. Research Progress in Chinese Herbal Medicines for Treatment of Sepsis: Pharmacological Action, Phytochemistry, and Pharmacokinetics.
Cheng C; Yu X
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681737
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining].
Fan T; Chen Y; Bai Y; Ma F; Wang H; Yang Y; Chen J; Lin Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(2):260-269. PubMed ID: 32391675
[TBL] [Abstract][Full Text] [Related]
3. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.
Wang Z; Yang L
J Ethnopharmacol; 2021 Apr; 270():113869. PubMed ID: 33485973
[TBL] [Abstract][Full Text] [Related]
4. Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis.
Fan TT; Cheng BL; Fang XM; Chen YC; Su F
Am J Chin Med; 2020; 48(6):1315-1330. PubMed ID: 32907362
[TBL] [Abstract][Full Text] [Related]
5. Herbal medicines for viral myocarditis.
Liu ZL; Liu ZJ; Liu JP; Kwong JS
Cochrane Database Syst Rev; 2013 Aug; (8):CD003711. PubMed ID: 23986406
[TBL] [Abstract][Full Text] [Related]
6. [Treatment strategy and thought on classical herbal formulae for coronavirus disease 2019].
Su KL; Xiong XJ
Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(2):494-503. PubMed ID: 33645139
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.
Qi F; Tang W
Biosci Trends; 2021 Sep; 15(4):201-204. PubMed ID: 34193750
[TBL] [Abstract][Full Text] [Related]
8. Herbal medicines for viral myocarditis.
Liu ZL; Liu ZJ; Liu JP; Kwong JS
Cochrane Database Syst Rev; 2012 Nov; 11():CD003711. PubMed ID: 23152220
[TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research.
Wang J; Qi F
Drug Discov Ther; 2020; 14(3):149-150. PubMed ID: 32669523
[TBL] [Abstract][Full Text] [Related]
10. [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
Zhang YS; Cong WH; Zhang JJ; Guo FF; Li HM
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1263-1271. PubMed ID: 32281335
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019].
Gu M; Liu J; Shi NN; Li XD; Huang ZD; Wu JK; Wang YG; Wang YP; Zhai HQ; Wang YY
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1253-1258. PubMed ID: 32281333
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Chinese Herbal Formulae Recommended for COVID-19 in Different Schemes in China: A Data Mining Approach.
Yin L; Gao Y; Li Z; Wang M; Chen K
Comb Chem High Throughput Screen; 2021; 24(7):957-967. PubMed ID: 33001008
[TBL] [Abstract][Full Text] [Related]
13. The current evidence for the treatment of sepsis with Xuebijing injection: Bioactive constituents, findings of clinical studies and potential mechanisms.
Li C; Wang P; Li M; Zheng R; Chen S; Liu S; Feng Z; Yao Y; Shang H
J Ethnopharmacol; 2021 Jan; 265():113301. PubMed ID: 32860891
[TBL] [Abstract][Full Text] [Related]
14. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).
Huang YF; Bai C; He F; Xie Y; Zhou H
Pharmacol Res; 2020 Aug; 158():104939. PubMed ID: 32445956
[TBL] [Abstract][Full Text] [Related]
15. Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review.
Liu YX; Zhou YH; Jiang CH; Liu J; Chen DQ
Bioengineered; 2022 Mar; 13(3):5480-5508. PubMed ID: 35184680
[TBL] [Abstract][Full Text] [Related]
16. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
[TBL] [Abstract][Full Text] [Related]
17. Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines.
Li C; Jia WW; Yang JL; Cheng C; Olaleye OE
Acta Pharmacol Sin; 2022 Dec; 43(12):3080-3095. PubMed ID: 36114271
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulation.
Cheng C; Ren C; Li MZ; Liu YH; Yao RQ; Yu Y; Yu X; Wang JL; Wang LX; Leng YC; Zhang H; Du FF; Dong N; Wang FQ; Wu Y; Xu F; Zhu XM; Zhang GP; Dong K; Liu S; Yao XQ; Li C; Yao YM
Acta Pharmacol Sin; 2024 May; 45(5):1077-1092. PubMed ID: 38267547
[TBL] [Abstract][Full Text] [Related]
20. The flower head of Chrysanthemum morifolium Ramat. (Juhua): A paradigm of flowers serving as Chinese dietary herbal medicine.
Yuan H; Jiang S; Liu Y; Daniyal M; Jian Y; Peng C; Shen J; Liu S; Wang W
J Ethnopharmacol; 2020 Oct; 261():113043. PubMed ID: 32593689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
